Interestingly, I went into the Rolex store about 5 months ago and they didn't have any actual watches on the floor - just displays. I talked with the lady for a while and expressed some interest in a few of the less popular models like the Yachtmaster and Explorer II (I don't really have any interest in Submariners). Didn't put my name on the list or anything, just talked with her for half an hour. She suggested I buy some jewelry or a Tudor, neither of which I'm interested in.
They called me out of the blue yesterday. I was in a meeting and didn't take the call, but I'm wondering if they actually got something in or if it is just a courtesy call. I know the market is slowing down, but since I didn't even put my name on the list for anything, I wasn't expecting a call. I guess I'll call them back today and see.
Damn, crazy to see this thread at the top of the board. Wife and I just finished the entire series for the first time tonight. Amazing storytelling. Season 5 was a little over the top and the weakest of the bunch, but it did a really nice job of wrapping up story lines and tying up loose ends. Great series. Glad it ended when it did - way too many go on way too long and I just have to stop watching them. This was great from start to finish.
Any other suggestions for good series to watch? I didn't catch any series done before around 2015.
Not if you don't have a history. Same with the AP RO and VC Overseas. You might be able to get lesser models within a reasonable time frame and start building a buying history though.
I'm not overly interested in those anyways, except the Overseas is just a phenomenal watch. But I feel like you get more for your money with independent brands now. Hand finishing quality, innovation, and the opportunity to develop a relationship with the brand and even the person who actually makes your watch.
I'd personally go with a Parmigiani Fleurier, Laurent Ferrier, Gronenfeld, Moser, or Czapek before the name brands. You don't get the name prestige, if that matters. But you get the same or better watch. Although those are getting hard to source as well as they have gained in popularity over the past couple years and production that is a fraction of PP/AP/VC.
Do you mean flip as in buy one new and turn around and sell it or just sell ones you already own? Selling a watch isn't "flipping".
That said, the hype watches from Rolex/PP/AP/VC are definitely down already and seems like they'll continue dropping. There's also a softening in the watch market as a whole (due to US/World events), but less so for the watches that aren't multiples of retail. Right now its mostly impacting grey market dealers who overextended based on the expectation that prices would continue to rise, as well as idiots paying those crazy prices (although they don't have to sell). I imagine if this continues to head down over an extended period of time, you'll see a LOT fewer fly by night grey market watch shops. For those with liquidity and/or the ability to weather the storm, it might be an opportunity.
I still like independent brands with extremely low production. They aren't as liquid because they aren't well known, but there are so few available it doesn't take much demand. Just a month ago, Czapek announced they were halting orders on the Antarctique de Drake for a year and orders placed prior were only guaranteed to arrive by EOY 2024. Moser prices have gone up slightly since the beginning of the year and remain steady. I anticipate an announcement with Moser and a non-watch brand this month which may generate some excitement. Other independents like Parmagiani Fleurier also remain quite popular.
There are a lot more people who can buy a luxury watch when the price is going up than the number of people who can buy a luxury watch when the prices aren't going up. This will be a big, and well-needed shakeup and hopefully return some sanity to the secondary market. For the longterm, that's a good thing. The pre-owned market is still going to grow over the coming years - but the craziness of the past 18-24 months is unsustainable.
There has definitely been the start of a correction, especially at the high end on hyped watches like certain Rolex, PP, AP. This has a trickle down effect to some of the lesser models. I imagine we'll see a steeper correction upcoming as there are TONS of new watch flippers that are going to be left holding the bag on these hype models that exploded earlier in the year.
The war, inflation, crypto, and general stock market issues are definitely reducing confidence in the watch market as a whole and its definitely slowed down and I'd say you can find some deals over the next 3-6 months. I would at least wait through the summer before buying any of the above brands as I think they will continue to come down more significantly than the rest of the watch market. That said, very low production independent brands still seem to be doing pretty decent.
My initial thought was negative on moving it back, but then I was thinking that if there's a 90 day commissioning period and the start was March 15th, then they would want time to evaluate and report the results of the commissioning which would end mid-June. So it makes sense to push it so they can report the results. Of course that would require good results to report. But that's speculation with some wishcasting thrown in for good measure.
I also think a lot of them release watches and build up a catalog, so they don't mind releasing early versions for little to no margin as they establish base customers.
It's basically direct crowdfunding without the crowdfunding source like Kickstarter. They want an idea of demand and some money in hand so they can manufacture the watches. Most of these microbrands are running on very small margins to keep the prices low, so this lets them fund their upcoming costs and reduce excess inventory which kills their small margin.
This was from a few days ago and led to it going up over $6. Seems like pretty good news. I realize its just Phase I, but with several other treatments also in the pipeline, it seems like only 1 hitting would get this back up very significantly.
ImmunityBio Inc (NASDAQ: IBRX) achieved a significant milestone with over 80 subjects in the QUILT-3.032 study completing at least 12 months of follow-up as of January 14.
QUILT-3.032 is evaluating VesAnktiva plus BCG in subjects with BCG-unresponsive non-muscle invasive bladder cancer carcinoma in situ (NMIBC CIS).
All data have been locked and analyzed.
The results continue to demonstrate a sustained clinically meaningful benefit.
Also See: ImmunityBio's Ankitva Shows 100% Survival At Two Years In Bladder Cancer Setting.
The U.S. marketing application has been compiled and, following final quality review, is expected to be submitted to the FDA this month.
The FDA granted Fast Track Designation to the pivotal trial based on Phase 1 data.
"With 71% of the participants in this study having a complete response and a median duration of response of 26.6 months, we believe we have a clinically meaningful therapeutic alternative for patients suffering from NMIBC in which the only option remaining is total cystectomy," said Patrick Soon-Shiong, Executive Chairman and Global Chief Scientific and Medical Officer
Price Action: IBRX shares closed 4.13% higher at $6.05 during after-hours trading on Friday.
Also, this:
Is there something underlying this stock that keeps it in the shitter, other than my owning it? Or maybe that is the problem.